What else do I need to worry about when treating graft-versus-host disease?

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Graft-versus-host disease (GVHD) is a primary cause of morbidity and mortality post-allogeneic hematopoietic stem cell transplant.
• GVHD significantly impairs patients' quality of life (QOL), physical functioning, and psychological well-being.

Observation:

• Patients with GVHD describe it as a life-altering condition requiring extensive self-management and coping strategies.
• GVHD affects multiple domains of patient-reported QOL, including physical and psychological health.

Findings:

• Effective management necessitates monitoring QOL and symptoms, screening for psychological distress, and multidisciplinary care.
• Addressing supportive care needs includes managing infection complications in immunocompromised patients.

Implications:

• Improving QOL in GVHD patients requires a multidisciplinary approach focused on symptom control, psychological support, and rehabilitation.
• Aggressive management and adaptation strategies are vital for patients facing prognostic uncertainty and the challenges of GVHD.